Literature DB >> 17109515

Comparison of gene expression profiles between primary tumor and metastatic lesions in gastric cancer patients using laser microdissection and cDNA microarray.

Long Wang1, Jin-Shui Zhu, Ming-Quan Song, Guo-Qiang Chen, Jin-Lian Chen.   

Abstract

AIM: To study the differential gene expression profiles of target cells in primary gastric cancer and its metastatic lymph nodes using laser microdissection (LMD) in combination with cDNA microarray.
METHODS: Normal gastric tissue samples from 30 healthy individuals, 36 cancer tissue samples from primary gastric carcinoma and lymph node metastasis tissue samples from 58 patients during gastric cancer resection were obtained using LMD in combination with cDNA microarray independently. After P27-based amplification, aRNA from 36 of 58 patients (group 1) with lymph node metastasis and metastatic tissue specimens from the remaining 22 patients (group 2) were applied to cDNA microarray. Semiquantitative reverse transcriptase polymerase chain reaction (RT-PCR) and immunohistochemical assay verified the results of microarray in group 2 and further identified genes differentially expressed in the progression of gastric cancer.
RESULTS: The expression of 10 genes was up-regulated while the expression of 15 genes was down-regulated in 22 gastric carcinoma samples compared with that of genes in the normal controls. The results were confirmed at the level of mRNA and protein, and suggested that four genes (OPCML, RNASE1, YES1 and ACK1) could play a key role in the tumorigenesis and metastasis of gastric cancer. The expression pattern of 3 genes (OPCML, RNASE1 and YES1) was similar to tumor suppressor genes. For example, the expression level of these genes was the highest in normal gastric epithelium, which was decreased in primary carcinoma, and further decreased in metastatic lymph nodes. On the contrary, the expression pattern of gene ACK1 was similar to that of oncogene. Four genes were further identified as differentially expressed genes in the majority of the cases in the progression of gastric cancer.
CONCLUSION: LMD in combination with cDNA microarray provides a unique support foe the identification of early expression profiles of differential genes and the expression pattern of 3 genes (OPCML, RNASE1 and YES1) associated with the progression of gastric cancer. Further study is needed to reveal the molecular mechanism of lymph node metastasis in patients with gastric cancer.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17109515      PMCID: PMC4087337          DOI: 10.3748/wjg.v12.i43.6949

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  29 in total

1.  Identification of the anti-angiogenic site within vascular basement membrane-derived tumstatin.

Authors:  Y Maeshima; M Manfredi; C Reimer; K A Holthaus; H Hopfer; B R Chandamuri; S Kharbanda; R Kalluri
Journal:  J Biol Chem       Date:  2001-02-07       Impact factor: 5.157

2.  Overexpression of a stabilized mutant form of the cyclin-dependent kinase inhibitor p27(Kip1) inhibits cell growth.

Authors:  Jean A Hurteau; Susan A Brutkiewicz; Qi Wang; Bernadette M Allison; Mark G Goebl; Maureen A Harrington
Journal:  Gynecol Oncol       Date:  2002-07       Impact factor: 5.482

3.  Modulation of astrocyte proliferation by cyclin-dependent kinase inhibitor p27(Kip1).

Authors:  Ken Koguchi; Yuji Nakatsuji; Kei-Ichi Nakayama; Saburo Sakoda
Journal:  Glia       Date:  2002-02       Impact factor: 7.452

4.  Novel targets for the 18p11.3 amplification frequently observed in esophageal squamous cell carcinomas.

Authors:  Koichi Nakakuki; Issei Imoto; Atiphan Pimkhaokham; Yoji Fukuda; Yutaka Shimada; Masayuki Imamura; Teruo Amagasa; Johji Inazawa
Journal:  Carcinogenesis       Date:  2002-01       Impact factor: 4.944

5.  Analysis of the gene-expression profile regarding the progression of human gastric carcinoma.

Authors:  Masaki Mori; Koshi Mimori; Yasuji Yoshikawa; Kenji Shibuta; Tohru Utsunomiya; Noriaki Sadanaga; Fumiaki Tanaka; Ayumi Matsuyama; Hiroshi Inoue; Keizo Sugimachi
Journal:  Surgery       Date:  2002-01       Impact factor: 3.982

Review 6.  Molecular profiling of human cancer.

Authors:  L Liotta; E Petricoin
Journal:  Nat Rev Genet       Date:  2000-10       Impact factor: 53.242

Review 7.  Molecular determinants of colon cancer metastasis.

Authors:  C A Portera; R S Berman; L M Ellis
Journal:  Surg Oncol       Date:  1998 Nov-Dec       Impact factor: 3.279

8.  An adenovirus expressing mutant p27 showed more potent antitumor effects than adenovirus-p27 wild type.

Authors:  K H Park; J Y Seol; T Y Kim; C G Yoo; Y W Kim; S K Han; Y S Shim; C T Lee
Journal:  Cancer Res       Date:  2001-08-15       Impact factor: 12.701

Review 9.  Critical determinants of metastasis.

Authors:  Isaiah J Fidler
Journal:  Semin Cancer Biol       Date:  2002-04       Impact factor: 15.707

Review 10.  Histone acetylation and gastrointestinal carcinogenesis.

Authors:  Wataru Yasui; Naohide Oue; Shigehiro Ono; Yoshitsugu Mitani; Reiko Ito; Hirofumi Nakayama
Journal:  Ann N Y Acad Sci       Date:  2003-03       Impact factor: 5.691

View more
  27 in total

1.  Somatic mutation in the ACK1 ubiquitin association domain enhances oncogenic signaling through EGFR regulation in renal cancer derived cells.

Authors:  Boon Tin Chua; Shu Jing Lim; Su Chin Tham; Wei Jie Poh; Axel Ullrich
Journal:  Mol Oncol       Date:  2010-03-19       Impact factor: 6.603

2.  Loss of opioid binding protein/cell adhesion molecule-like gene expression in gastric cancer.

Authors:  Ning Zhang; Jide Xu; Yuhong Wang; Xuhua Heng; Liteng Yang; Xiangbin Xing
Journal:  Oncol Lett       Date:  2018-04-24       Impact factor: 2.967

Review 3.  Laser capture microdissection in the tissue biorepository.

Authors:  Angen Liu
Journal:  J Biomol Tech       Date:  2010-09

4.  Expression of ovarian tumour suppressor OPCML in the female CD-1 mouse reproductive tract.

Authors:  Jean S Fleming; H James McQuillan; Melanie J Millier; Grant C Sellar
Journal:  Reproduction       Date:  2009-01-27       Impact factor: 3.906

5.  Gene profiles between non-invasive and invasive colon cancer using laser microdissection and polypeptide analysis.

Authors:  Jin-Shui Zhu; Hua Guo; Ming-Quan Song; Guo-Qiang Chen; Qun Sun; Qiang Zhang
Journal:  World J Gastroenterol       Date:  2008-10-14       Impact factor: 5.742

6.  To What Extent is Blood a Reasonable Surrogate for Brain in Gene Expression Studies: Estimation from Mouse Hippocampus and Spleen.

Authors:  Matthew N Davies; Sarah Lawn; Steven Whatley; Cathy Fernandes; Robert W Williams; Leonard C Schalkwyk
Journal:  Front Neurosci       Date:  2009-10-09       Impact factor: 4.677

7.  miRNA expression profile in primary gastric cancers and paired lymph node metastases indicates that miR-10a plays a role in metastasis from primary gastric cancer to lymph nodes.

Authors:  Weidong Chen; Zhaoqing Tang; Yihong Sun; Youyou Zhang; Xuefei Wang; Zhenbin Shen; Fenglin Liu; Xinyu Qin
Journal:  Exp Ther Med       Date:  2011-12-06       Impact factor: 2.447

8.  Synthetic lethality of TNK2 inhibition in PTPN11-mutant leukemia.

Authors:  Chelsea Jenkins; Samuel B Luty; Julia E Maxson; Christopher A Eide; Melissa L Abel; Corinne Togiai; Eneida R Nemecek; Daniel Bottomly; Shannon K McWeeney; Beth Wilmot; Marc Loriaux; Bill H Chang; Jeffrey W Tyner
Journal:  Sci Signal       Date:  2018-07-17       Impact factor: 8.192

9.  Identification and Characterization of Tyrosine Kinase Nonreceptor 2 Mutations in Leukemia through Integration of Kinase Inhibitor Screening and Genomic Analysis.

Authors:  Julia E Maxson; Melissa L Abel; Jinhua Wang; Xianming Deng; Sina Reckel; Samuel B Luty; Huahang Sun; Julie Gorenstein; Seamus B Hughes; Daniel Bottomly; Beth Wilmot; Shannon K McWeeney; Jerald Radich; Oliver Hantschel; Richard E Middleton; Nathanael S Gray; Brian J Druker; Jeffrey W Tyner
Journal:  Cancer Res       Date:  2015-12-17       Impact factor: 12.701

Review 10.  Metastasis: a therapeutic target for cancer.

Authors:  Patricia S Steeg; Dan Theodorescu
Journal:  Nat Clin Pract Oncol       Date:  2008-02-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.